21st Orphan Drugs and Rare Diseases Global Congress 2024 Europe
Innovative programmes to optimize access in a global healthcare market
Thursday 11th - Friday 12th April 2024
KEY INDUSTRY EXPERT SPEAKERS
- Rüdiger Schulze, VP & GM, Germany & Central/Eastern Europe, Ultragenyx
- Nick Sireau, Chair & CEO, AKU Society
- Sheela Upadhyaya, Chair Elect, Rare Disease Special Interest Group, ISPOR
- David Pearce, President, Innovation & Research, Sanford Health
- Nigel Nicholls, General Manager UK/Nordics & Baltics, Egetis Therapeutics AB
- Alexander Natz, Secretary General, EUCOPE
- Anne-Sophie Chalandon, Head of Global Rare Diseases and CGT Policy, Sanofi
- Owen Marks, Head of Rare Diseases and Diversity and Inclusion Co-Chair, Pfizer
- Anthony Hall, Chief Medical Officer, Healx
- Arti Patel, Genomics Associate, Great Ormond Street Hospital, Trustee, Treacher Collins Family Support and Gene People UK
- Kerry Leeson-Beevers, Chief Executive, Alström Syndrome UK
- Amanda Bok, Chief Strategy Officer, The Synergist
- Nicholas Brooke, Founder & Executive Director, Synergist
- Bob Stevens, Group CEO, MPS Society
- Melanie Dixon, Trustee, Cure DHDDS
- Carole Scrafton, Director & Co-Founder, Flutters and Strutters
- Dr Usman Khan, Chair, Motor Neurone Disease (MND) Association
- Manuela Maronati, Head of Europe, Rare Disease Organization, UCB
- Rohan Simon, Associate Director - Business Development, Insights Research Organization & Solutions, an M42 Company
- Dr. Ron Jortner, Founder/CEO, Aspire Biosciences
- Joshua Card-Gowers, Senior Evidence Lead, HealthLumen
- Julie Powell, Director of Patient Advocacy and Public Affairs, Pleco Therapeutics
- Lindsay Randall, Founder, CEO, Mother, Arthur’s Quest
- Hazel Dawson, Market Access Director, UK & Ireland, Alexion Pharma
- Dr. Harriet Holme, Chair and Founder, PCDResearch.org
- Josie Godfrey, Director, JG Zebra Consulting, Joint CEO, Realise Advocacy
- Dr Peter Lanyon, Rare Diseases Clinical Lead, NHS England
- Pr Daniel Scherman, Head of Medicine, Life Sciences Division, European Academy of Sciences
- Dr. Femida Gwadry-Sridhar, Founder and CEO, Pulse infoframe Inc.
- Juliet Hulse, Head of Clinical Operations, Pulse infoframe Inc.
- Dan Lewi, Head of Business Development and Patient Advocacy , Pulse infoframe Inc., Co- founder, CATS Foundation
- Surabhi Verma, Chief Medical Officer, Leadiant Biosciences
![](https://www.orphandrugscongress.com/wp-content/uploads/2023/02/D-Pearce-1.png)
David Pearce
President of Innovation, Research, & World Clinic
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/02/A-Chalandon.png)
Anne-Sophie Chalandon
Head of Global Rare Diseases and CGT Policy
![](https://www.orphandrugscongress.com/wp-content/uploads/2023/02/P-Franco.png)
Pedro Franco
Director for Global Regulatory & Scientific Policy (GRASP)
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/02/A-bok.png)
Amanda Bok
Chief Strategy Officer
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/OMarks.png)
OWEN MARKS
Principal, OMGEN, Head of Rare Diseases and Diversity and Inclusion Co-Chair
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/02/A-Patel.png)
Arti Patel
Genomics Associate, Great Ormond Street Hospital, Trustee
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/MMaronati.png)
MANUELA MARONATI
Head of Rare Disease Europe
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/02/A-Natz-2.png)
Alexander Natz
Secretary General
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/02/N-Nicholls-2.png)
Nigel Nicholls
General Manager UK/Nordics & Baltics
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/N-Brooke.png)
NICHOLAS BROOKE
Founder & Executive Director
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/Julie-1.png)
Julie Powell
Director, Patient Advocacy and Public Affairs
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/KerryLB.png)
KERRY LEESON-BEEVERS
Chief Executive
![](https://www.orphandrugscongress.com/wp-content/uploads/2023/03/S-Upadhaya.png)
Sheela Upadhyaya
Chair Elect, Rare Disease Special Interest Group
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/Speakers-Photo-2024-04-08T163643.554.png)
Dr. Femida Gwadry-Sridhar
Founder and CEO
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/02/N-Sireau.png)
Nick Sireau
Chair & CEO
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/UKhan-1.png)
DR USMAN KHAN
Chair
![](https://www.orphandrugscongress.com/wp-content/uploads/2023/04/B-Stevens.png)
BOB STEVENS
Group CEO
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/M-Dixon.png)
MELANIE DIXON
Trustee
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/RJortner.png)
DR. RON JORTNER
Founder/CEO
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/CScafton.png)
CAROLE SCRAFTON
Director & Co-Founder
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/03/R-Simon.png)
ROHAN SIMON
Associate Director - Business Development
![](https://www.orphandrugscongress.com/wp-content/uploads/2023/04/A-Hall.png)
ANTHONY HALL
Chief Medical Officer
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/Joshua.png)
JOSHUA CARD-GOWERS
Senior Evidence Lead
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/L-Randall-1.png)
LINDSAY RANDALL
Founder, CEO, Mother
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/H-Holme.png)
DR. HARRIET HOLME
Chair and Founder
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/H-Dawson.png)
HAZEL DAWSON
Market Access Director UK & Ireland
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/S-Verma.png)
SURABHI VERMA
Chief Medical Officer
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/J-Hulse-2.png)
JULIET HULSE
Head of Clinical Operations
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/D-Lewi-2.png)
DAN LEWI
Head of Business Development and Patient Advocacy
Pulse infoframe Inc., Co- founder, CATS Foundation
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/D-Lewi-2.png)
DAN LEWI
Head of Business Development and Patient Advocacy
![](https://www.orphandrugscongress.com/wp-content/uploads/2024/04/R-Donnell-1.png)
ROBERT DONNELL
Executive Vice President – Medicines Access